Alimera Sciences reported $173K in Operating Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3753M 498M
Aerie Pharmaceuticals AERI:US $ -35.59M 1.99M
Alimera Sciences ALIM:US $ 0.17M 0.23M
Applied Genetic Technologies AGTC:US $ -15.12M 0.05M
Bayer BAYN:GR 1.52B 10.91B
Insmed INSM:US $ -94538000 38.32M
Novartis NOVN:VX 2.64B 232M
Ophthotech OPHT:US $ -25.48M 6.48M
Regeneron Pharmaceuticals REGN:US $ 1167M 113.9M